Results from GTx's Phase 2 clinical trial of enobosarm published online

[News]

GTx, Inc. today announced that the journal, The Lancet Oncology, has published online ahead of its April print edition the results from GTx's randomized, double-blind, placebo-controlled Phase 2 clinical trial of enobosarm to assess its effects on muscle wasting and physical function in patients with cancer.

More... (http://www.news-medical.net/news/20130315/Results-from-GTxs-Phase-2-clinical-trial-of-enobosarm-published-online.aspx)